Management of metastatic renal cell carcinoma patients with poor-risk features: current status and future perspectives

  • Matteo Santoni, Michele De Tursi, Alessandra Felici, Giovanni Lo Re, Riccardo Ricotta, Enzo Maria Ruggeri, Roberto Sabbatini, Daniele Santini, Vanja Vaccaro, Michele Milella
  • Expert Review of Anticancer Therapy, June 2013, Taylor & Francis
  • DOI: 10.1586/era.13.52

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

The following have contributed to this page: Dr Matteo Santoni, Dr Michele Milella, MICHELE DE TURSI, and Giovanni Lo Re